1. Home
  2. CUVL vs FSBW Comparison

CUVL vs FSBW Comparison

Compare CUVL & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clinuvel Pharmaceuticals Limited American Depositary Shares

CUVL

Clinuvel Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$5.18

Market Cap

374.2M

Sector

Miscellaneous

ML Signal

N/A

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

N/A

Current Price

$43.19

Market Cap

332.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CUVL
FSBW
Founded
1999
1936
Country
Australia
United States
Employees
N/A
537
Industry
Miscellaneous
Banks
Sector
Miscellaneous
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
374.2M
332.6M
IPO Year
2004
2011

Fundamental Metrics

Financial Performance
Metric
CUVL
FSBW
Price
$5.18
$43.19
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
★ $45.50
AVG Volume (30 Days)
4.5K
★ 24.7K
Earning Date
08-27-2026
10-21-2026
Dividend Yield
0.55%
★ 2.66%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 2.62
Revenue
N/A
★ $4,612,000.00
Revenue This Year
$0.47
$5.22
Revenue Next Year
$6.25
$9.03
P/E Ratio
★ N/A
$21.22
Revenue Growth
N/A
★ 44.80
52 Week Low
$4.81
$36.66
52 Week High
$8.20
$45.85

Technical Indicators

Market Signals
Indicator
CUVL
FSBW
Relative Strength Index (RSI) 46.35 40.73
Support Level $4.86 $41.49
Resistance Level $6.00 $44.40
Average True Range (ATR) 0.27 1.01
MACD 0.05 -0.10
Stochastic Oscillator 27.69 34.18

Price Performance

Historical Comparison
CUVL
FSBW

About CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of First Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: